Role of Ozone Therapy in Preventing Testicular Damage in an Experimental Cryptorchid Rat Model
- PMID: 30130360
- PMCID: PMC6113856
- DOI: 10.12659/MSM.910459
Role of Ozone Therapy in Preventing Testicular Damage in an Experimental Cryptorchid Rat Model
Abstract
BACKGROUND Cryptorchidism is the most common developmental abnormality of the male reproductive system. If left untreated, it results with infertility and testicular cancer. According to current evidence, surgery is the mainstay of treatment, and hormonal therapy approaches are still under investigation. For the protection of testicular functions, antioxidants have emerged as novel options. This study aimed to evaluate the protective properties of ozone, a strong antioxidant, on testicular tissue. MATERIAL AND METHODS Thirty-five male Wistar-albino rats, 1-month-old, were used for the study. Groups were formed as follows: 1) control, 2) sham surgery (cryptorchidism), 3) cryptorchidism plus ozone, 4) cryptorchidism plus human chorionic gonadotropin (hCG), and 5) ozone plus hCG. Surgical procedures were performed on all rats except the control group. All rats except the control group were used to create an experimental cryptorchidism model, and left testes of animals were surgically placed into the abdomen. After 1 month of surgery, groups 3, 4, and 5 were given corresponding treatments intraperitoneally for 4 weeks. At the end of the study period, testicular atrophy index (TAI) and testicular sperm motility (TSM) were assessed and biochemical, histopathological, and immunohistochemical tests were performed. RESULTS TAI and TSM were higher in the ozone, hCG, and ozone plus hCG groups than in the sham surgery group (p=0.001). TSM in the ozone group was significantly higher than in the hCG and ozone plus hCG groups. In biochemical analyses, the parameters of oxidative stress (GPx1, MDA, CAT, GSH, SOD) indicated increased oxidative activity in cryptorchidism, which was resolved by applying ozone and hCG (p=0.001). In addition, apoptotic markers, Caspase 3 and bcl-2 were significantly decreased by applying ozone and hCG (p=0.001). CONCLUSIONS Results of this study suggest that ozone therapy, either as a single agent or in combination with hCG, is a promising approach for protection of testicular functions.
Conflict of interest statement
None.
Figures
Similar articles
-
The influence of hormonal treatment with beta-human chorionic gonadotropin for cryptorchidism on future fertility in rats.J Pediatr Urol. 2015 Apr;11(2):92.e1-4. doi: 10.1016/j.jpurol.2014.12.011. Epub 2015 Mar 10. J Pediatr Urol. 2015. PMID: 25819376
-
Effects of experimental cryptorchidism on sperm motility and testicular endocrinology in adult male rats.J Reprod Dev. 2006 Apr;52(2):219-28. doi: 10.1262/jrd.17073. Epub 2006 Jan 16. J Reprod Dev. 2006. PMID: 16415524
-
Post-fertilization effect of bilateral primary testicular damage induced by unilateral cryptorchidism in the rat model.Andrology. 2016 Mar;4(2):297-305. doi: 10.1111/andr.12154. Epub 2016 Jan 12. Andrology. 2016. PMID: 26757429
-
Studies of cryptorchidism in experimental animal models.Acta Paediatr. 2007 May;96(5):617-21. doi: 10.1111/j.1651-2227.2007.00295.x. Acta Paediatr. 2007. PMID: 17462054 Review.
-
Hormonal Aspects of the Pathogenesis and Treatment of Cryptorchidism.Eur J Pediatr Surg. 2016 Oct;26(5):409-417. doi: 10.1055/s-0036-1592415. Epub 2016 Sep 19. Eur J Pediatr Surg. 2016. PMID: 27642852 Review.
Cited by
-
Early Life Oxidative Stress and Long-Lasting Cardiovascular Effects on Offspring Conceived by Assisted Reproductive Technologies: A Review.Int J Mol Sci. 2020 Jul 22;21(15):5175. doi: 10.3390/ijms21155175. Int J Mol Sci. 2020. PMID: 32707756 Free PMC article. Review.
-
The effects of ozone and melatonin on busulfan-induced testicular damage in mice.JBRA Assist Reprod. 2021 Apr 27;25(2):176-184. doi: 10.5935/1518-0557.20200081. JBRA Assist Reprod. 2021. PMID: 33507719 Free PMC article.
References
-
- Serrano T, Chevrier C, Multigner L, et al. International geographic correlation study of the prevalence of disorders of male reproductive health. Hum Reprod. 2013;28(7):1974–86. - PubMed
-
- Brucker-Davis F, Pointis G, Chevallier D, et al. Update on cryptorchidism: Endocrine, environmental and therapeutic aspects. J Endocrinol Invest. 2003;26(6):575–87. - PubMed
-
- Trussell JC, Lee PA. The relationship of cryptorchidism to fertility. Curr Urol Rep. 2004;5(2):142–48. - PubMed
-
- Wood HM, Elder JS. Cryptorchidism and testicular cancer: Separating fact from fiction. J Urol. 2009;181(2):452–61. - PubMed
-
- Ferlin A, Zuccarello D, Garolla A, et al. Hormonal and genetic control of testicular descent. Reprod Biomed Online. 2007;15(6):659–65. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous